1 active not recruiting. 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 1 | Active not recruiting 1 |
Follow Stage I Chronic Lymphocytic Leukemia: new trials by email Literature Review of Stage I Chronic Lymphocytic Leukemia trials Research Report on Stage I Chronic Lymphocytic Leukemia
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Rituximab and Bendamustine Hydrochloride, Rituximab and Ibrutinib, or Ibrutinib Alone in Treating Older Patients With Previously Untreated Chronic Lymphocytic Leukemia Bendamustine Hydrochloride, Biospecimen Collection, Bone Marrow Aspiration - Stage I Chronic Lymphocytic Leukemia, Stage II Chronic Lymphocytic Leukemia | Phase 3 | Active not recruiting | National Cancer Institute (NCI) | 547 | 2014-01-15 | 2026-10-22 |
Leukemia, Lymphocytic, Chronic, B-Cell (1)
Chronic Disease (1) · Disease Attributes (1) · Hematologic Diseases (1) · Hemic and Lymphatic Diseases (1) · Immune System Diseases (1) · Immunoproliferative Disorders (1) · Leukemia (1) · Leukemia, B-Cell (1) · Leukemia, Lymphoid (1) · Lymphatic Diseases (1) · Lymphoproliferative Disorders (1) · Neoplasms (1) · Neoplasms by Histologic Type (1) · Pathologic Processes (1) · Pathological Conditions, Signs and Symptoms (1)
Bendamustine Hydrochloride (1) · Biopsy (1) · CT-P10 (1) · Rituximab (1) · Specimen Handling (1) · ibrutinib (1)
National Cancer Institute (NCI) (1)
Canada (1) · United States (1)
PMID 30501481, PMID 34274940, PMID 38215395
K23CA178183 (1), R01CA183444 (1), U10CA031946 (1), U10CA180821 (1)